Run Sheng Jiang
Präsident bei WALVAX BIOTECHNOLOGY CO., LTD.
Vermögen: 3 Mio $ am 31.05.2024
Aktive Positionen von Run Sheng Jiang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
WALVAX BIOTECHNOLOGY CO., LTD. | Direktor/Vorstandsmitglied | 12.08.2019 | - |
Präsident | 22.06.2016 | - | |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Vorsitzender | - | - |
Karriereverlauf von Run Sheng Jiang
Statistik
International
China | 3 |
Operativ
Director/Board Member | 1 |
President | 1 |
Chairman | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Health Technology |
- Börse
- Insiders
- Run Sheng Jiang
- Erfahrung